Leo Wealth LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Leo Wealth LLC's XBI Position: Q2 2025 in Review
Leo Wealth LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 4,275 shares — an estimated $347K sold.
Leo Wealth LLC first reported a position in XBI in Q4 2023 and held it in 6 quarters. The position peaked at $423K in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.
- Leo Wealth LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
- Leo Wealth LLC sold 4,275 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $347K.
- Leo Wealth LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 6 quarters.
- Leo Wealth LLC's State Street SPDR S&P Biotech ETF position peaked at $423K in Q3 2024.
- 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.
Based on Leo Wealth LLC's 13F filing for Q2 2025, filed 24 Jul 2025.